2 Nijhuis ER,Nijman HW,Oien KA, et al. Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. J Clin Pathol, 2007,60(7):824~830.
3 Peltomaki P.DNA mismatch repair and cancer.Mutat Res, 2001,488(1):77~85.
4 Skarda J , Fridman E , Kolar Z, et al . Prognostic value of hMLH1 and hMSH2 immunohistochemical expression in non2small cell lung cancer. A tissue microarray study.Biomed Pap Med Fac University Palacky OlomoucCzech Repub,2006,150(2) :255.
5 Hayashi T,Arai M. Frequency of immunohistochemical loss of mismatch repair protein in double primary cancers of the colorectum and stomach in Japan. Dis Colon Rectum,2006,49(10):S23~29.
7 Smigiel R,StembalskaKozlowska A,Mirghomizadeh F,et al.Correlation among loss of heterozygosity, promoter methylation and protein expression of MLH1 in larynx cancer. Oncol Rep,2004,11(3):707~710.
8 Lipkin S M,Wang V ,Jacoby R,et al . MLH3 : a DNA mismatch repair gene assoeiated with mammalian mecrosatellite instability. Nat Genet,2000,24(l):27~35.
9 LinksLiu R , Yin L H , Pu Y P. Reduced expression of human DNA repair genes in esophageal squamouscell carcinoma in china. Toxicol Environ Health A ,2007,70(11):956~963.
10 Graziella Castrilli ,Fabiano A , La Torre G,et al . Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors. Oral Pathology ,2002,31(4):234~238.
11 Jennifer L. Hunt ,MD Warthin Tumors Do Not Have Microsatellite Instability and Express Normal DNA Mismatch Repair Proteins Head and Neck & Endocrine Pathology , Archives of Pathology and Laboratory ,2006,130 (1) :52~56.
12 Karran P ,Offman J ,Bignami M. Human mismatch repair ,druginduced DNA damages , and secondary cancer.Biochimie ,2003,85 (11):1149~1160.
13 Giarnieri E ,Mancini R ,Pisani T ,et al. Msh2 ,Mlh1 , Fhit ,p53 ,Bcl-2 ,and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res ,2000,6(6):3600~3606.
14 HiroakiM, Nada HK, Liya G, et al. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett,2005,223(1): 143~150.
15 Helleman J, van Staveren IL, DinjensWN, et al. Mismatch repair and treatment resistance in ovarian cancer. BMC Cancer,2006,6:201~208.